FAIZ UDDIN: Open Payments
NPI 1114900016 · RADCLIFF, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$953 in 64 payments from 7 companies in 2025. Trend: 2023 $450 · 2024 $462 · 2025 $953
Food & beverage: $953
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $311 |
| AstraZeneca Pharmaceuticals LP | 4 | $259 |
| Viatris Specialty LLC | 12 | $194 |
| PFIZER INC. | 15 | $136 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: AIRSUPRA, YUPELRI, QULIPTA, NURTEC ODT, UBRELVY, VRAYLAR, Auvelity, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
